Pfizer sees $10-$15 billion in annual mRNA vaccine revenue by 2030
The company provided potential revenue details from vaccines across its portfolio, including its already-approved COVID-19 vaccine…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
XELJANZ
US FDA adds strict safety warnings on arthritis drugs from Pfizer, AbbVie and Lilly
The US Food and Drug Administration's boxed warnings on the labels of Rinvoq , Xeljanz and Olumiant flags the risk of…
Xeljanz receives marketing authorisation in EU to treat active polyarticular juvenile idiopathic…
This once-daily treatment is an alternative to the currently-approved Xeljanz 5 mg twice-daily treatment of PsA
Pfizer get USFDA nod for XELJANZ (tofacitinib) to treat active polyarticular course juvenile…
Two formulations were approved, a tablet and an oral solution, and are dosed based upon weight